Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd is rated 'Hold' by MarketsMOJO. This rating was last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Niva Bupa Health Insurance Company Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a nuanced picture of momentum and trend strength that investors should carefully analyse.

Niva Bupa Health Insurance Company Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Niva Bupa Health Insurance Company Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a modest day gain of 1.18%, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse before making decisions.

Niva Bupa Health Insurance Company Ltd has witnessed a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions amid a complex backdrop of sector dynamics and peer comparisons, prompting investors to reassess the stock’s price attractiveness in the insurance space.

Niva Bupa Health Insurance Company Ltd witnessed one of the highest trading volumes in the market on 31 Jul 2026, with over 7.64 million shares changing hands. Despite this surge in activity, the stock closed lower by 1.21% at ₹86.22, reflecting a complex interplay of investor sentiment amid sector gains and shifting ratings.

Niva Bupa Health Insurance Company Ltd. delivered a robust first quarter for FY2027, posting net profit of ₹137.80 crores, representing a remarkable 92.93% year-on-year surge from ₹71.44 crores in Q1 FY26. However, the sequential performance revealed a different narrative, with profits declining 13.54% from the preceding quarter's ₹159.36 crores. The stock closed at ₹85.83 on July 31, down 0.14% on the day, trading near its 52-week high of ₹91.39 but carrying a premium valuation that raises questions about sustainability at a market capitalisation of ₹15,871.97 crores.

Niva Bupa Health Insurance Company Ltd has reported a robust quarterly performance for June 2026, marked by record net sales and significant profit growth, although its nine-month profitability trend remains subdued. The company’s financial trend rating has shifted from very positive to positive, reflecting a nuanced outlook amid strong quarterly gains and some longer-term challenges.

Niva Bupa Health Insurance Company Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late July 2026. Despite a slight dip in the daily price, key technical indicators such as MACD, moving averages, and Bollinger Bands suggest a cautiously optimistic outlook for this small-cap insurance player, which has outperformed the Sensex year-to-date.

Niva Bupa Health Insurance Company Ltd has recently experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite mixed returns relative to the broader market, the stock’s technical indicators suggest growing investor optimism, supported by positive signals from MACD, moving averages, and Bollinger Bands.

Niva Bupa Health Insurance Company Ltd has seen its investment rating downgraded from Buy to Hold as of 22 July 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite strong long-term fundamentals and robust quarterly results, evolving market dynamics and valuation concerns have tempered enthusiasm among analysts.

Niva Bupa Health Insurance Company Ltd has experienced a subtle shift in its technical momentum, transitioning from a bullish to a mildly bullish stance. Despite a recent dip in price, the stock’s underlying indicators suggest a nuanced outlook, with mixed signals from key technical parameters such as MACD, RSI, and moving averages. This analysis delves into the latest technical trends and market context to provide a comprehensive view for investors.

Niva Bupa Health Insurance Company Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 July 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Niva Bupa Health Insurance Company Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish stance as of early July 2026. Despite a modest day gain of 0.89%, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting both the company’s resilience and the broader market’s cautious sentiment.